尽管年轻患者和HLA匹配,但旅行基SCT中GVHD的患病率很高。

Naveed Syed, Imrana Afrooz, Farooq Ahmed Mir, Azmat Ali Khan, Nada J M H Abdulla, Shakir Hussain, Ashok Uttam Chandani, Amera Hassan, Hanin Abdel Samad, Gehad ElGhazali, Shahrukh Hashmi
{"title":"尽管年轻患者和HLA匹配,但旅行基SCT中GVHD的患病率很高。","authors":"Naveed Syed, Imrana Afrooz, Farooq Ahmed Mir, Azmat Ali Khan, Nada J M H Abdulla, Shakir Hussain, Ashok Uttam Chandani, Amera Hassan, Hanin Abdel Samad, Gehad ElGhazali, Shahrukh Hashmi","doi":"10.18502/ijhoscr.v19i2.18551","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b>: Patients from regions without stem cell transplantation (SCT) facilities often seek treatment abroad and return home for post-transplant care. Although extensive data exist on graft-versus-host disease (GVHD) and its risk factors, information on international SCT patients returning to countries that lack transplant facilities and expertise is scarce and not well documented. <b>Materials and Methods</b>: We screened 149 transplant recipients and analyzed the data of 91 patients who received transplants abroad and were followed up at our center from January 2019 to December 2022. This observational study used data from electronic medical records and employed descriptive statistics, inferential tests, and relative risk calculations with forest plots to analyze the prevalence of GVDH and its key risk factors. <b>Results</b>: Of the recipients, 31.8% were residents of nine countries residing in the UAE, and 67.2% were UAE citizens. Adults comprised 48.3% of the recipients, whereas 51.7% were pediatric patients. Hematological malignancy was the most common indication (49%), primarily in adults. Siblings comprised the majority of donors (52.6%), followed by related (23.09%) and unrelated donors (8.9%). Most patients (69.2%) received HLA-identical transplants, followed by 21.9% who received haplo-identical transplants. Among adults, 62.2% developed GVHD compared to 26% of pediatric patients. Recipients from related HLA-identical donors had a 50% prevalence of GVDH, whereas those from unrelated identical donors had a 71% prevalence. The overall prevalence of GVDH was 50% in 87.9% of patients who received allogeneic SCTs. <b>Conclusion</b>: Despite favorable factors, such as young age and matched related donors, we found a high prevalence of GVDH. Ocular GVHD was less prevalent than expected, and lung GVHD was weakly correlated with established risk factors. Larger multicenter studies are needed to assess and confirm the effect of contributing factors.</p>","PeriodicalId":94048,"journal":{"name":"International journal of hematology-oncology and stem cell research","volume":"19 2","pages":"138-150"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368712/pdf/","citationCount":"0","resultStr":"{\"title\":\"High GVHD Prevalence in Travel-Based SCT despite Young Patients and HLA Matching.\",\"authors\":\"Naveed Syed, Imrana Afrooz, Farooq Ahmed Mir, Azmat Ali Khan, Nada J M H Abdulla, Shakir Hussain, Ashok Uttam Chandani, Amera Hassan, Hanin Abdel Samad, Gehad ElGhazali, Shahrukh Hashmi\",\"doi\":\"10.18502/ijhoscr.v19i2.18551\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background</b>: Patients from regions without stem cell transplantation (SCT) facilities often seek treatment abroad and return home for post-transplant care. Although extensive data exist on graft-versus-host disease (GVHD) and its risk factors, information on international SCT patients returning to countries that lack transplant facilities and expertise is scarce and not well documented. <b>Materials and Methods</b>: We screened 149 transplant recipients and analyzed the data of 91 patients who received transplants abroad and were followed up at our center from January 2019 to December 2022. This observational study used data from electronic medical records and employed descriptive statistics, inferential tests, and relative risk calculations with forest plots to analyze the prevalence of GVDH and its key risk factors. <b>Results</b>: Of the recipients, 31.8% were residents of nine countries residing in the UAE, and 67.2% were UAE citizens. Adults comprised 48.3% of the recipients, whereas 51.7% were pediatric patients. Hematological malignancy was the most common indication (49%), primarily in adults. Siblings comprised the majority of donors (52.6%), followed by related (23.09%) and unrelated donors (8.9%). Most patients (69.2%) received HLA-identical transplants, followed by 21.9% who received haplo-identical transplants. Among adults, 62.2% developed GVHD compared to 26% of pediatric patients. Recipients from related HLA-identical donors had a 50% prevalence of GVDH, whereas those from unrelated identical donors had a 71% prevalence. The overall prevalence of GVDH was 50% in 87.9% of patients who received allogeneic SCTs. <b>Conclusion</b>: Despite favorable factors, such as young age and matched related donors, we found a high prevalence of GVDH. Ocular GVHD was less prevalent than expected, and lung GVHD was weakly correlated with established risk factors. Larger multicenter studies are needed to assess and confirm the effect of contributing factors.</p>\",\"PeriodicalId\":94048,\"journal\":{\"name\":\"International journal of hematology-oncology and stem cell research\",\"volume\":\"19 2\",\"pages\":\"138-150\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368712/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of hematology-oncology and stem cell research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/ijhoscr.v19i2.18551\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of hematology-oncology and stem cell research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijhoscr.v19i2.18551","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:来自没有干细胞移植(SCT)设施的地区的患者经常在国外寻求治疗并返回国内接受移植后护理。尽管存在大量关于移植物抗宿主病(GVHD)及其危险因素的数据,但关于返回缺乏移植设施和专业知识的国家的国际SCT患者的信息很少,也没有很好的记录。材料与方法:筛选149例移植受者,分析2019年1月至2022年12月在我中心接受国外移植并随访的91例患者的数据。本观察性研究使用电子病历数据,并采用描述性统计、推断检验和森林样地的相对风险计算来分析GVDH的患病率及其关键危险因素。结果:在受助人中,31.8%是居住在阿联酋的9个国家的居民,67.2%是阿联酋公民。成年人占48.3%,而儿科患者占51.7%。血液系统恶性肿瘤是最常见的适应症(49%),主要见于成人。兄弟姐妹占献血者的大多数(52.6%),其次是亲属(23.09%)和非亲属(8.9%)。大多数患者(69.2%)接受了相同的hla移植,其次是21.9%的患者接受了单倍相同的移植。在成人中,62.2%的患者发生GVHD,而儿科患者的这一比例为26%。同源hla供者的受体GVDH患病率为50%,而同源hla供者的受体GVDH患病率为71%。在接受同种异体sct的87.9%的患者中,GVDH的总体患病率为50%。结论:尽管有有利因素,如年轻和匹配的相关供体,我们发现GVDH的患病率很高。眼部GVHD的患病率低于预期,而肺部GVHD与既定危险因素的相关性较弱。需要更大规模的多中心研究来评估和确认促成因素的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

High GVHD Prevalence in Travel-Based SCT despite Young Patients and HLA Matching.

High GVHD Prevalence in Travel-Based SCT despite Young Patients and HLA Matching.

High GVHD Prevalence in Travel-Based SCT despite Young Patients and HLA Matching.

High GVHD Prevalence in Travel-Based SCT despite Young Patients and HLA Matching.

Background: Patients from regions without stem cell transplantation (SCT) facilities often seek treatment abroad and return home for post-transplant care. Although extensive data exist on graft-versus-host disease (GVHD) and its risk factors, information on international SCT patients returning to countries that lack transplant facilities and expertise is scarce and not well documented. Materials and Methods: We screened 149 transplant recipients and analyzed the data of 91 patients who received transplants abroad and were followed up at our center from January 2019 to December 2022. This observational study used data from electronic medical records and employed descriptive statistics, inferential tests, and relative risk calculations with forest plots to analyze the prevalence of GVDH and its key risk factors. Results: Of the recipients, 31.8% were residents of nine countries residing in the UAE, and 67.2% were UAE citizens. Adults comprised 48.3% of the recipients, whereas 51.7% were pediatric patients. Hematological malignancy was the most common indication (49%), primarily in adults. Siblings comprised the majority of donors (52.6%), followed by related (23.09%) and unrelated donors (8.9%). Most patients (69.2%) received HLA-identical transplants, followed by 21.9% who received haplo-identical transplants. Among adults, 62.2% developed GVHD compared to 26% of pediatric patients. Recipients from related HLA-identical donors had a 50% prevalence of GVDH, whereas those from unrelated identical donors had a 71% prevalence. The overall prevalence of GVDH was 50% in 87.9% of patients who received allogeneic SCTs. Conclusion: Despite favorable factors, such as young age and matched related donors, we found a high prevalence of GVDH. Ocular GVHD was less prevalent than expected, and lung GVHD was weakly correlated with established risk factors. Larger multicenter studies are needed to assess and confirm the effect of contributing factors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信